Vyvanse (lisdexamfetamine) coverage has improved significantly since generic lisdexamfetamine became available in 2023. Most insurance plans now cover the generic version on lower tiers with affordable copays. Vyvanse is approved for both ADHD and binge eating disorder, though coverage for BED may require additional prior authorization documentation.
Key Facts
Check Your Specific Plan's Formulary
Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.
Open Formulary CheckerSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Yes. Generic lisdexamfetamine dimesylate has been available since August 2023 from multiple manufacturers. Most pharmacies now stock the generic, and most insurance plans prefer it over brand Vyvanse. If your pharmacy dispenses brand Vyvanse, ask if they have the generic in stock, as it will be significantly cheaper.
Many plans cover Vyvanse (or generic) for binge eating disorder (BED), but prior authorization is typically required. Your doctor will need to document the BED diagnosis, severity, and any failed behavioral interventions. Coverage may be more restrictive than for ADHD.
It depends on your state and plan. Some states restrict stimulant prescriptions to 30-day supplies due to controlled substance regulations. Other states allow 90-day supplies. Mail-order pharmacies may offer 90-day supplies where permitted. Check with your insurer and state pharmacy board.
Related Resources
- UnitedHealthcare Formulary 2026
- Aetna Formulary 2026
- Cigna Formulary 2026
- Adderall cash price comparison on RxGrab
- Concerta cash price comparison on RxGrab
- Ritalin cash price comparison on RxGrab
- Strattera cash price comparison on RxGrab
- Wellbutrin cash price comparison on RxGrab
- Patient assistance programs
- Patient assistance programs
- Patient assistance programs
- Drug interaction checker tool
- Patient assistance program finder
Get Formulary and Coverage Updates
Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.